MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Medroxyprogesterone

Medroxyprogesterone 2.5mg tablets

Use with caution

Stability notes for Medroxyprogesterone 2.5mg tablets

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 2.5mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 2.5mg tablets (Pfizer Ltd).

Supplier

Medroxyprogesterone 2.5mg tablets (Pfizer Ltd)

Medroxyprogesterone 5mg tablets

Use with caution

Stability notes for Medroxyprogesterone 5mg tablets

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 5mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 5mg tablets (Pfizer Ltd).

Suppliers (5) of Medroxyprogesterone 5mg tablets
Medroxyprogesterone 5mg tablets (Pfizer Ltd)
Provera 5mg tablets (CST Pharma Ltd)
Provera 5mg tablets (Necessity Supplies Ltd)
Provera 5mg tablets (Pfizer Ltd)
Provera 5mg tablets (Sigma Pharmaceuticals Plc)

Medroxyprogesterone 10mg tablets

Use with caution

Stability notes for Medroxyprogesterone 10mg tablets

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 10mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 10mg tablets (Pfizer Ltd).

Suppliers (6) of Medroxyprogesterone 10mg tablets
Medroxyprogesterone 10mg tablets (Pfizer Ltd)
Provera 10mg tablets (CST Pharma Ltd)
Provera 10mg tablets (Lexon (UK) Ltd)
Provera 10mg tablets (Necessity Supplies Ltd)
Provera 10mg tablets (Pharmaram Ltd)
Provera 10mg tablets (Sigma Pharmaceuticals Plc)

Medroxyprogesterone 100mg tablets

Use with caution

Stability notes for Medroxyprogesterone 100mg tablets

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 100mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 100mg tablets (Pfizer Ltd).

Suppliers

Medroxyprogesterone 100mg tablets (Pfizer Ltd)
Provera 100mg tablets (Pfizer Ltd)

Medroxyprogesterone 200mg tablets

Use with caution

Stability notes for Medroxyprogesterone 200mg tablets

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 200mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 200mg tablets (Pfizer Ltd).

Supplier

Medroxyprogesterone 200mg tablets (Pfizer Ltd)

Medroxyprogesterone 400mg tablets

Use with caution

Stability notes for Medroxyprogesterone 400mg tablets

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 400mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 400mg tablets (Pfizer Ltd).

Supplier

Medroxyprogesterone 400mg tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.